1. Home
  2. NXL vs LMFA Comparison

NXL vs LMFA Comparison

Compare NXL & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • LMFA
  • Stock Information
  • Founded
  • NXL 2010
  • LMFA 2008
  • Country
  • NXL United States
  • LMFA United States
  • Employees
  • NXL N/A
  • LMFA N/A
  • Industry
  • NXL Medical Specialities
  • LMFA Finance: Consumer Services
  • Sector
  • NXL Health Care
  • LMFA Finance
  • Exchange
  • NXL Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • NXL 14.0M
  • LMFA 11.9M
  • IPO Year
  • NXL 2022
  • LMFA 2015
  • Fundamental
  • Price
  • NXL $0.85
  • LMFA $1.22
  • Analyst Decision
  • NXL Strong Buy
  • LMFA Strong Buy
  • Analyst Count
  • NXL 1
  • LMFA 1
  • Target Price
  • NXL $5.00
  • LMFA $5.00
  • AVG Volume (30 Days)
  • NXL 2.9M
  • LMFA 737.8K
  • Earning Date
  • NXL 11-07-2025
  • LMFA 11-12-2025
  • Dividend Yield
  • NXL N/A
  • LMFA N/A
  • EPS Growth
  • NXL N/A
  • LMFA N/A
  • EPS
  • NXL N/A
  • LMFA N/A
  • Revenue
  • NXL $174,813.00
  • LMFA $6,755,925.00
  • Revenue This Year
  • NXL $38.28
  • LMFA N/A
  • Revenue Next Year
  • NXL $185.71
  • LMFA $6.50
  • P/E Ratio
  • NXL N/A
  • LMFA N/A
  • Revenue Growth
  • NXL 16.42
  • LMFA N/A
  • 52 Week Low
  • NXL $0.59
  • LMFA $1.02
  • 52 Week High
  • NXL $4.49
  • LMFA $5.14
  • Technical
  • Relative Strength Index (RSI)
  • NXL 46.92
  • LMFA 39.11
  • Support Level
  • NXL $0.79
  • LMFA $1.05
  • Resistance Level
  • NXL $0.99
  • LMFA $1.21
  • Average True Range (ATR)
  • NXL 0.08
  • LMFA 0.09
  • MACD
  • NXL 0.01
  • LMFA 0.04
  • Stochastic Oscillator
  • NXL 32.38
  • LMFA 60.66

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: